These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20865533)

  • 1. Docking to large allosteric binding sites on protein surfaces.
    Ramirez UD; Myachina F; Stith L; Jaffe EK
    Adv Exp Med Biol; 2010; 680():481-8. PubMed ID: 20865533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphobilinogen synthase: An equilibrium of different assemblies in human health.
    Jaffe EK
    Prog Mol Biol Transl Sci; 2020; 169():85-104. PubMed ID: 31952692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allostery and the dynamic oligomerization of porphobilinogen synthase.
    Jaffe EK; Lawrence SH
    Arch Biochem Biophys; 2012 Mar; 519(2):144-53. PubMed ID: 22037356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric inhibition of human porphobilinogen synthase.
    Lawrence SH; Ramirez UD; Selwood T; Stith L; Jaffe EK
    J Biol Chem; 2009 Dec; 284(51):35807-17. PubMed ID: 19812033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Remarkable Character of Porphobilinogen Synthase.
    Jaffe EK
    Acc Chem Res; 2016 Nov; 49(11):2509-2517. PubMed ID: 27783504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).
    Tang L; Breinig S; Stith L; Mischel A; Tannir J; Kokona B; Fairman R; Jaffe EK
    J Biol Chem; 2006 Mar; 281(10):6682-90. PubMed ID: 16377642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.
    Kokona B; Rigotti DJ; Wasson AS; Lawrence SH; Jaffe EK; Fairman R
    Biochemistry; 2008 Oct; 47(40):10649-56. PubMed ID: 18795796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shape shifting leads to small-molecule allosteric drug discovery.
    Lawrence SH; Ramirez UD; Tang L; Fazliyez F; Kundrat L; Markham GD; Jaffe EK
    Chem Biol; 2008 Jun; 15(6):586-96. PubMed ID: 18559269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and molecular characterization of a novel porphobilinogen synthase from Corynebacterium glutamicum.
    Zhu D; Wu C; Niu C; Li H; Ge F; Li W
    World J Microbiol Biotechnol; 2023 Apr; 39(6):165. PubMed ID: 37071336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.
    Breinig S; Kervinen J; Stith L; Wasson AS; Fairman R; Wlodawer A; Zdanov A; Jaffe EK
    Nat Struct Biol; 2003 Sep; 10(9):757-63. PubMed ID: 12897770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morpheeins--a new structural paradigm for allosteric regulation.
    Jaffe EK
    Trends Biochem Sci; 2005 Sep; 30(9):490-7. PubMed ID: 16023348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of quaternary structure dynamics on allosteric drug discovery.
    Jaffe EK
    Curr Top Med Chem; 2013; 13(1):55-63. PubMed ID: 23409765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-induced interconversion of protein quaternary structure isoforms.
    Tang L; Stith L; Jaffe EK
    J Biol Chem; 2005 Apr; 280(16):15786-93. PubMed ID: 15710608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plastid-associated porphobilinogen synthase from Toxoplasma gondii: kinetic and structural properties validate therapeutic potential.
    Shanmugam D; Wu B; Ramirez U; Jaffe EK; Roos DS
    J Biol Chem; 2010 Jul; 285(29):22122-31. PubMed ID: 20442414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALAD porphyria is a conformational disease.
    Jaffe EK; Stith L
    Am J Hum Genet; 2007 Feb; 80(2):329-37. PubMed ID: 17236137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation.
    Jaffe EK; Shanmugam D; Gardberg A; Dieterich S; Sankaran B; Stewart LJ; Myler PJ; Roos DS
    J Biol Chem; 2011 Apr; 286(17):15298-307. PubMed ID: 21383008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase.
    Frankenberg N; Erskine PT; Cooper JB; Shoolingin-Jordan PM; Jahn D; Heinz DW
    J Mol Biol; 1999 Jun; 289(3):591-602. PubMed ID: 10356331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodobacter capsulatus porphobilinogen synthase, a high activity metal ion independent hexamer.
    Bollivar DW; Clauson C; Lighthall R; Forbes S; Kokona B; Fairman R; Kundrat L; Jaffe EK
    BMC Biochem; 2004 Nov; 5():17. PubMed ID: 15555082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme.
    Lawrence SH; Selwood T; Jaffe EK
    ChemMedChem; 2011 Jun; 6(6):1067-73. PubMed ID: 21506274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and thermodynamics of the interchange of the morpheein forms of human porphobilinogen synthase.
    Selwood T; Tang L; Lawrence SH; Anokhina Y; Jaffe EK
    Biochemistry; 2008 Mar; 47(10):3245-57. PubMed ID: 18271513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.